Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.
Viale G, Basik M, Niikura N, Tokunaga E, Brucker S, Penault-Llorca F, Hayashi N, Sohn J, Teixeira de Sousa R, Brufsky AM, O'Brien CS, Schmitt F, Higgins G, Varghese D, James GD, Moh A, Livingston A, de Giorgio-Miller V. Viale G, et al. Among authors: niikura n. ESMO Open. 2023 Aug;8(4):101615. doi: 10.1016/j.esmoop.2023.101615. Epub 2023 Aug 8. ESMO Open. 2023. PMID: 37562195 Free PMC article.
Biomarker discordance during tumor progression.
Niikura N, Ueno NT. Niikura N, et al. Cancer Biomark. 2012-2013;12(6):205-6. doi: 10.3233/CBM-130321. Cancer Biomark. 2012. PMID: 23735940 No abstract available.
Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer.
Hayashi N, Iwamoto T, Gonzalez-Angulo AM, Ferrer-Lozano J, Lluch A, Niikura N, Bartholomeusz C, Nakamura S, Hortobagyi GN, Ueno NT. Hayashi N, et al. Among authors: niikura n. Oncologist. 2011;16(7):956-65. doi: 10.1634/theoncologist.2010-0409. Epub 2011 Jun 28. Oncologist. 2011. PMID: 21712485 Free PMC article.
A prospective study of bone tumor response assessment in metastatic breast cancer.
Hayashi N, Costelloe CM, Hamaoka T, Wei C, Niikura N, Theriault RL, Hortobagyi GN, Madewell JE, Ueno NT. Hayashi N, et al. Among authors: niikura n. Clin Breast Cancer. 2013 Feb;13(1):24-30. doi: 10.1016/j.clbc.2012.09.004. Epub 2012 Oct 24. Clin Breast Cancer. 2013. PMID: 23098575 Free PMC article.
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer.
Hayashi N, Niikura N, Yamauchi H, Nakamura S, Ueno NT. Hayashi N, et al. Among authors: niikura n. Breast Cancer Res Treat. 2013 Jan;137(2):523-31. doi: 10.1007/s10549-012-2336-6. Epub 2012 Nov 27. Breast Cancer Res Treat. 2013. PMID: 23184079 Free PMC article.
122 results